VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.
Position in DGX — Quest Diagnostics Inc
CIK 1367401
AMSTERDAM, P7
Position in DGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$50,229,282
+$19,836,197 QoQ
Shares Held
256,298
+46.3% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 65.68837837205128.ToString("F0")%
Shared 0.ToString("F0")%
None 34.31162162794872.ToString("F0")%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. holds $403,398,357 across 6 Diagnostics & Research names. DGX ranks #3 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
440,724 | $216,629,067 | |
| 2 | ICLR |
Icon PLC
|
918,713 | $101,664,780 | |
| 3 | DGX |
Quest Diagnostics Inc
This page
|
256,298 | $50,229,282 | |
| 4 | QGEN |
Qiagen N.V.
|
431,253 | $17,267,370 | |
| 5 | DHR |
Danaher Corp /De/
|
52,537 | $9,961,015 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
44,839 | $7,646,843 |
All Filings in DGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,229,282 | 256,298 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,393,085 | 175,146 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $65,112,228 | 341,653 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $73,324,966 | 408,200 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $72,975,960 | 431,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $77,626,219 | 514,558 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $61,017,131 | 393,025 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $48,782,663 | 356,390 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||